InvAscent bets on Mumbai drugmaker Sunways in third deal of 2022

 InvAscent bets on Mumbai drugmaker Sunways in third deal of 2022
Healthcare-focused private equity firm InvAscent has struck its third new deal this year by investing $15 million (Rs 123 crore) in Mumbai-based pharmaceutical company Sunways India Pvt Ltd. InvAscent invested in the company via its India Life Sciences Fund III (ILSF III) and picked up a minority stake. Sunways said […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest